NDC 0338-0722

PEMETREXED

Pemetrexed

PEMETREXED is a Intraventricular Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Pemetrexed Disodium Heptahydrate.

Product ID0338-0722_94c2f5f8-332c-4552-9919-0ae23b014788
NDC0338-0722
Product TypeHuman Prescription Drug
Proprietary NamePEMETREXED
Generic NamePemetrexed
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENTRICULAR
Marketing Start Date2022-08-18
Marketing CategoryANDA /
Application NumberANDA214436
Labeler NameBaxter Healthcare Corporation
Substance NamePEMETREXED DISODIUM HEPTAHYDRATE
Active Ingredient Strength500 mg/50mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0338-0722-01

1 VIAL, SINGLE-DOSE in 1 CARTON (0338-0722-01) > 50 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2022-08-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PEMETREXED" or generic name "Pemetrexed"

NDCBrand NameGeneric Name
0338-0720PEMETREXEDPEMETREXED
0338-0722PEMETREXEDPEMETREXED
0409-1045PEMETREXEDPEMETREXED
0409-1060PemetrexedPemetrexed
0409-1061PemetrexedPemetrexed
0409-1062PemetrexedPemetrexed
0409-2188PEMETREXEDPEMETREXED
0409-3532PEMETREXEDPEMETREXED
0480-4514PemetrexedPemetrexed
0480-4515PemetrexedPemetrexed
0480-4516PemetrexedPemetrexed
0781-3518PemetrexedPemetrexed disodium
0781-3519PemetrexedPemetrexed disodium
0781-3520PemetrexedPemetrexed disodium
16729-229PemetrexedPemetrexed
16729-230PemetrexedPemetrexed
16729-244PemetrexedPemetrexed
16729-522PemetrexedPemetrexed disodium
50742-340PemetrexedPemetrexed disodium
50742-341PemetrexedPemetrexed disodium
55150-381PemetrexedPemetrexed
55150-382PemetrexedPemetrexed
42367-531Pemfexypemetrexed
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.